Shinnosuke Takemoto

Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial

Kohei Otsubo, Junji Kishimoto, Masahiko Ando et al. · European Respiratory Journal · 2022 · 83 citations

Medicine, Oncology, Pharmacology +14

Comparison of platinum combination chemotherapy plus pembrolizumab versus platinum combination chemotherapy plus nivolumab–ipilimumab for treatment-naive advanced non-small-cell lung cancer in Japan (JCOG2007): an open-label, multicentre, randomised, phase 3 trial

Yoshimasa Shiraishi, Shogo Nomura, Shunichi Sugawara et al. · The Lancet Respiratory Medicine · 2024 · 39 citations

Medicine, Oncology, Pharmacology +17

Impact of tumor programmed death ligand-1 expression on osimertinib efficacy in untreated EGFR-mutated advanced non-small cell lung cancer: a prospective observational study

Akihiro Yoshimura, Tadaaki Yamada, Yusuke Okuma et al. · Translational Lung Cancer Research · 2021 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

Significance of a positive crossmatch on outcome in human liver transplantation.

K. Ogura, Hidenori Koyama, Shinnosuke Takemoto et al. · PubMed · 1992 · 21 citations

Medicine, Immunology, Surgery +14

High levels of <scp>AXL</scp> expression in untreated <scp><i>EGFR</i></scp>‐mutated non‐small cell lung cancer negatively impacts the use of osimertinib

Akihiro Yoshimura, Tadaaki Yamada, Masakuni Serizawa et al. · Cancer Science · 2022 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17